Andrew Reaume
Vorstandsvorsitzender bei Melior Discovery, Inc.
Aktive Positionen von Andrew Reaume
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Melior Discovery, Inc.
 Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Vorstandsvorsitzender | 01.01.2005 | - |
| Gründer | 01.01.2005 | - | |
| Präsident | 01.01.2005 | - | |
Melior Pharmaceuticals I, Inc.
 Melior Pharmaceuticals I, Inc. Pharmaceuticals: MajorHealth Technology Melior Pharmaceuticals I, Inc. operates as a clinical stage pharmaceutical company. The private company is based in Exton, PA. The company was founded in 2008 by Andrew G Reaume. | Präsident | 01.12.2008 | - |
| Gründer | 01.12.2008 | - | |
| Vorstandsvorsitzender | 01.12.2008 | - |
Karriereverlauf von Andrew Reaume
Ehemalige bekannte Positionen von Andrew Reaume
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 01.01.1993 | 01.01.1999 |
| ADHERA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 09.09.2021 | - |
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Andrew Reaume
| University of Connecticut | Doctorate Degree |
| University of Pennsylvania | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Chief Executive Officer | 3 |
| Founder | 3 |
| President | 3 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Commercial Services |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Melior Pharmaceuticals I, Inc.
Melior Pharmaceuticals I, Inc. Pharmaceuticals: MajorHealth Technology Melior Pharmaceuticals I, Inc. operates as a clinical stage pharmaceutical company. The private company is based in Exton, PA. The company was founded in 2008 by Andrew G Reaume. | Health Technology |
- Börse
- Insiders
- Andrew Reaume
- Erfahrung